Spinocerebellar Ataxia Type 7 (SCA7) is a rare inherited neurological disorder that affects movement, coordination, and vision. It belongs to a group of conditions known as the spinocerebellar ataxias, which are characterized by progressive degeneration of the cerebellum and other parts of the nervous system. While SCA7 is uncommon, genetic testing can play an important role in diagnosis, family planning, and understanding future health risks.
What Causes SCA7?
SCA7 is caused by a change (variant) in the ATXN7 gene. Specifically, the condition results from an expansion of a DNA sequence known as a CAG repeat. Most people have a relatively small number of these repeats within the ATXN7 gene. Individuals with SCA7 have an abnormally expanded number of repeats, which causes the gene to produce an abnormal protein that gradually damages nerve cells.
One of the distinctive features of SCA7 is a phenomenon called anticipation. This means the number of CAG repeats can increase when passed from one generation to the next, often resulting in earlier onset and more severe symptoms in children than in their affected parent.
What Are the Symptoms?
The symptoms of SCA7 vary between individuals and can develop at different ages, ranging from childhood to late adulthood. The hallmark features include:
- Progressive problems with balance and coordination (ataxia)
- Difficulty walking
- Slurred speech (dysarthria)
- Poor hand coordination
- Abnormal eye movements
- Vision loss due to degeneration of the retina
The vision problems associated with SCA7 are particularly significant and help distinguish it from many other forms of spinocerebellar ataxia. Individuals may initially notice difficulty reading, trouble seeing colours, or reduced central vision. Over time, vision impairment can become severe.
As the condition progresses, some individuals may also experience muscle stiffness, swallowing difficulties, and weakness.
How Is SCA7 Inherited?
SCA7 follows an autosomal dominant inheritance pattern. This means a person only needs to inherit one altered copy of the ATXN7 gene to develop the condition.
If a parent has SCA7, each child has a 50% chance of inheriting the altered gene and being at risk of developing the condition. Because of anticipation, the condition may appear at a younger age or with greater severity in subsequent generations.
Genetic counselling is strongly recommended for individuals and families affected by SCA7 to discuss inheritance risks, testing options, and family planning considerations.
How Is SCA7 Diagnosed?
Diagnosis often begins with a neurological assessment and a review of personal and family medical history. Because symptoms can overlap with other neurological disorders, genetic testing is usually required to confirm the diagnosis.
A genetic test can identify the CAG repeat expansion in the ATXN7 gene and provide a definitive diagnosis. In families where a pathogenic expansion has already been identified, predictive testing may be available for adult relatives who wish to learn whether they have inherited the condition.
Is There a Treatment?
Currently, there is no cure for SCA7 and no treatment that can stop disease progression. Management focuses on addressing symptoms and maintaining quality of life.
A multidisciplinary care team may include neurologists, ophthalmologists, physiotherapists, occupational therapists, speech pathologists, and genetic counsellors. Supportive therapies can help individuals maintain mobility, communication, and independence for as long as possible.
Research into gene-targeted therapies and other novel treatments for inherited neurological conditions is ongoing, providing hope for future advances.
How Can Rosalind Genetics Help?
At Rosalind Genetics, we provide expert genetic counselling and access to comprehensive genetic testing for inherited neurological conditions, including Spinocerebellar Ataxia Type 7. Whether you have symptoms, a family history of ataxia, or questions about genetic risk, our team can help you understand your options and make informed decisions about your health and future.
Early diagnosis and genetic counselling can provide valuable information for affected individuals and their families, helping them navigate this complex condition with confidence and support.
